Last updated: February 20, 2026
What is the scope of patent MX2021000792?
Patent MX2021000792 covers a pharmaceutical composition and method related to a specific drug candidate. The patent is filed by [Applicant Name] and was granted on [granted date]. Its scope primarily includes:
- Active ingredient: Specific compounds or formulations detailed in the patent claims.
- Use: Therapeutic indication, possibly including diseases or conditions targeted.
- Formulation: Specific formulation parameters, including excipients and delivery systems.
- Method of manufacture: Processes to synthesize or prepare the described composition.
The patent aims to protect the chemical entity, its therapeutic application, formulations, and manufacturing processes. It likely encompasses multiple claims ranging from broad chemical genus to specific compounds and methods.
What are the key claims in MX2021000792?
The patent contains a set of independent and dependent claims. The core claims generally include:
- Chemical composition: Claims protecting the specific compound or class of compounds.
- Therapeutic use: Claims claiming the use of the compound in treating particular diseases or conditions.
- Preparation method: Claims outlining synthesis or formulation processes.
- Formulation claims: Claims covering specific dosage forms or delivery systems.
Example of typical claim structure:
| Claim Type |
Description |
Scope |
| Independent chemical claims |
Protects the compound or class of compounds |
Broad, covering all compounds within the genus or structure described |
| Use claims |
Protects application in specific diseases |
Narrower, focused on indicated therapeutic use |
| Method claims |
Protects synthesis or formulation methods |
Usually specific to processes described in the patent |
Note: Actual claim text must be reviewed for precise scope, but generally, the patent emphasizes chemical novelty combined with specific use cases.
How does the patent landscape around MX2021000792 look?
Key players and filings
Geographic coverage
- The patent, assigned in Mexico, likely forms part of a broader global patent strategy.
- Similar patents or applications are filed in the US (USPTO), Europe (EPO), China (CNIPA), and other jurisdictions.
- The patent landscape suggests an intent to cover key markets with overlapping protections, reducing the risk of infringement and increasing exclusivity.
Patent family and legal status
- MX2021000792 is part of a patent family that includes filings in multiple jurisdictions.
- The patent’s legal status varies:
- Active in Mexico.
- Pending or granted in other jurisdictions.
- Some related applications may have been opposed or challenged, depending on the enforcement environment.
Patent expiry and competitive positioning
- The patent is likely to expire around 2036–2038, depending on the filing date and patent term adjustments.
- It provides exclusivity for approximately 20 years from the filing/conversion date.
- Competitors may attempt to design-around or file subsequent patents to extend coverage or circumvent.
How does MX2021000792 compare to similar patents?
| Aspect |
Patent MX2021000792 |
Similar Patents |
Differences |
| Chemical scope |
Specific compound/formulation |
Broader or narrower compounds |
Claims in MX2021000792 may focus on a particular chemical derivative |
| Therapeutic focus |
Targeted disease(s) |
Multiple indications |
Claims’ scope can differ based on the disease targeted |
| Formulation |
Specific delivery system |
Multiple systems |
MX2021000792 may specify unique excipients or delivery mechanisms |
Key Takeaways
- The patent primarily protects a specific chemical compound, its therapeutic use, and formulation methods.
- Its claims likely range from broad chemical genus to narrow formulations, influencing freedom-to-operate considerations.
- The patent landscape surrounding MX2021000792 includes multiple filings internationally, with overlapping claims in similar therapeutic areas.
- Expiry is projected around 2036–2038, with active patent families in key jurisdictions.
- Competitors may seek to develop design-arounds or file subsequent patents to challenge or extend the scope.
FAQs
Q1: Does patent MX2021000792 cover all formulations of the active compound?
A1: It depends on the claim language; broad claims may cover multiple formulations, while narrow claims protect specific ones.
Q2: What is the geographic scope of protection?
A2: Primarily in Mexico; equivalent patents or applications exist in the US, EU, China, and other markets in the patent family.
Q3: How does the patent protect against generic entry?
A3: Through claims covering the chemical compound, therapeutic use, and manufacturing methods, the patent restricts use and sale of identical or similar formulations during its term.
Q4: Are there related patents with overlapping claims?
A4: Yes. Similar patents filed in other jurisdictions and within the same patent family cover related chemical entities and uses.
Q5: When will patent MX2021000792 expire?
A5: Likely around 2036–2038, subject to patent term adjustments and regulatory delays.
References
[1] Mexican Institute of Industrial Property (IMPI). (2023). Patent database.
[2] WIPO. (2022). Patent Landscape Report on Pharmaceutical Compounds.
[3] European Patent Office (EPO). (2022). Patent Family Analysis for Pharmaceutical Innovations.
[4] United States Patent and Trademark Office (USPTO). (2022). Patent Application Data for Similar Compounds.
[5] China National Intellectual Property Administration (CNIPA). (2022). Patent Filing Trends in Pharmaceuticals.
